Alector (ALEC) Change in Accured Expenses (2018 - 2026)
Alector (ALEC) reported Change in Accured Expenses of -$11.0 million for Q1 2026, up 13.35% year-over-year from -$9.7 million in Q1 2025, and down 1112.21% quarter-over-quarter from $1.1 million in Q4 2025.
Alector (ALEC) Change in Accured Expenses (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Change in Accured Expenses data on file, last reported at -$11.0 million in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$11.0 million, up 13.35% year-over-year; the trailing twelve-month figure through Mar 2026 was -$11.2 million (down 439.22% YoY), and the FY2025 annual result was -$12.9 million, down 3895.29% from the prior year.
- Change in Accured Expenses eased to -$11.0 million in Q1 2026 per ALEC's latest filing, from $1.1 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $8.0 million in Q3 2023 and troughed at -$12.7 million in Q1 2025.
- A 5-year average of -$1.4 million and a median of -$1.1 million in 2022 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses surged 823.83% in 2023, then sank 900.21% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at $4.6 million in 2022, then slumped by 145.79% to -$2.1 million in 2023, then surged by 420.84% to $6.8 million in 2024, then slumped by 84.0% to $1.1 million in 2025, then sank by 1112.21% to -$11.0 million in 2026.
- Business Quant data shows ALEC's Change in Accured Expenses at -$11.0 million in Q1 2026, $1.1 million in Q4 2025, and $2.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 931,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | -11.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.02 Mn |
| Mar 31, 2026 | -11.02 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Jun 30, 2025 | -3.79 Mn |
| Jun 30, 2025 | -3.79 Mn |
| Mar 31, 2025 | -12.72 Mn |
| Mar 31, 2025 | -12.72 Mn |
| Dec 31, 2024 | 6.81 Mn |
| Dec 31, 2024 | 6.81 Mn |
| Sep 30, 2024 | 3.37 Mn |
| Sep 30, 2024 | 3.37 Mn |
| Jun 30, 2024 | 473,000.00 |
| Jun 30, 2024 | 473,000.00 |
| Mar 31, 2024 | -10.30 Mn |
| Mar 31, 2024 | -10.30 Mn |
| Dec 31, 2023 | -2.12 Mn |
| Dec 31, 2023 | -2.12 Mn |